Albania
Tuberculosis profile
Population  2012 3.2 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–0.016) 0.31 (0.16–0.49)
Mortality (HIV+TB only)        
Prevalence  (includes HIV+TB) 0.68 (0.28–1.3) 22 (8.9–40)
Incidence  (includes HIV+TB) 0.51 (0.43–0.59) 16 (14–19)
Incidence (HIV+TB only)        
Case detection, all forms (%) 81 (69–95)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 185 (47) Relapse 17 (59)
Smear-negative 99 (25) Treatment after failure 0 (0)
Smear-unknown / not done 1 (<1) Treatment after default 4 (14)
Extrapulmonary 106 (27) Other 8 (28)
Other 0 (0)      
Total new 391   Total retreatment 29  
           
Other (history unknown) 0        
Total new and relapse 408   Total cases notified 420  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.5 1.8 1.9
Age < 15 0 2 1
Laboratories 2012
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 93   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 92  
Retreatment 83  
TB/HIV 2012 Number (%)
TB patients with known HIV status 233 (55)
HIV-positive TB patients 7 (3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 7 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 7 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT 2  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.58 (0.02–3.2) 0 (0–22)
MDR-TB cases among notified pulmonary
TB cases
2 (0–9) 0 (0–6)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 172 (76%) 15 (52%) 187
Laboratory-confirmed MDR-TB cases 1 0 1
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data